Abstract

We audited pain from ultrasound-guided core biopsies (CB) for routine service quality monitoring, to provide baseline data against which to compare new techniques, and to help us develop methodological expertise in pain assessment. Although there is no standard against which to audit CB pain, published comparators are available.

Highlights

  • National Institute for Health and Clinical Excellence (NICE) guidelines recommend conventional ultrasound (CU) of the axilla as preliminary staging in patients with breast cancer

  • We examined the prognostic effect of size of ipsilateral breast tumour recurrence (IBTR) and metachronous contralateral breast cancer (MCBC) to assess potential benefit of surveillance mammography after breast cancer treatment

  • Results were sensitive to primary tumour characteristics used to define the likelihoods of developing an IBTR or MCBC

Read more

Summary

Introduction

NICE guidelines recommend conventional ultrasound (CU) of the axilla as preliminary staging in patients with breast cancer. Methods A retrospective analysis of 277 patients referred for MRI-guided vacuum biopsies of impalpable breast lesions visible only on MRI was performed. Our protocol for assessment of women with screen-detected malignancy was changed to include bilateral whole breast and axillary ultrasound (BBUS) following a prospective study that confirmed the benefit of this in 2002 [1]. This audit assesses the impact of introducing this change. Triple-negative breast cancer (TNBC) cases comprise approximately 15% of newly diagnosed breast cancers and are associated with poor prognosis and limited treatment options In this retrospective study from South Wales, 81 patients with breast cancer found to be ER, PR and HER2 negative were reviewed to determine whether there are common imaging and pathological findings. This study was based on the hypothesis that recall of benign solitary masses might be a major contributor to this as no prior imaging is available

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.